Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens

PURPOSE: Patients previously treated with ketoconazole were excluded from phase III trials of abiraterone acetate due to potential overlapping mechanism of action. The purpose of this study was to determine the clinical utility of abiraterone and its impact on circulating androgens following ketocon...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Cancer Res
Main Authors: Kim, Won, Zhang, Li, Wilton, John H., Fetterly, Gerald, Mohler, James L., Weinberg, Vivian, Morse, Allison, Szmulewitz, Russell, Friedlander, Terence W., Fong, Lawrence, Lin, Amy M., Harzstark, Andrea, Molina, Arturo, Small, Eric J., Ryan, Charles J.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277885/
https://ncbi.nlm.nih.gov/pubmed/25336698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1595
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים